AbbVie Inc. is 46.0x more valuable than Nuvalent, Inc. by market capitalization ($397.44 B vs $8.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NUVL | ABBV |
|---|---|---|
| Market cap | $8.64 B | $397.44 B |
| US-listed rank | #1031 | #28 |
| Revenue (latest FY) | - | $61.16B |
| Net income (latest FY) | -$425.40M | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 529 | 1,008 |
AbbVie Inc. is 46.0x more valuable than Nuvalent, Inc. by market capitalization ($397.44 B vs $8.64 B).
Full pages: Nuvalent, Inc. and AbbVie Inc., or browse the full rankings.